Mike Cetera is the editor in chief of Forbes Advisor. He has written and edited articles about consumer finance for more than a decade. Prior to joining Marketplace, his work appeared on Bankrate, The ...
July 8, 2026 A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements than the leading oral semaglutide in a major clinical trial. The tablet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results